RecruitingNot ApplicableNCT05608694

MRI Screening in Men at High Risk of Developing Prostate Cancer


Sponsor

University of Chicago

Enrollment

250 participants

Start Date

Mar 2, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to determine whether or not Magnetic Resonance Images (MRI) will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer.


Eligibility

Sex: MALEMin Age: 18 Years

Inclusion Criteria3

  • Male age 18 and older
  • No known history of prostate cancer
  • No previous prostate resection or ablation (e.g. TURP, photovaporization)

Exclusion Criteria3

  • Unable to tolerate MRI due to metal fragments or claustrophobia
  • Lack of a rectum
  • Hip arthroplasty

Interventions

OTHERProstate MRI

Group placement is determined by GRS score, Family history, and germline testing


Locations(2)

University of Chicago

Chicago, Illinois, United States

NorthShore University Health System - Glenbrook Hospital

Glenview, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05608694


Related Trials